Molecular Formula | C27H24N6 |
Molar Mass | 432.52 |
Density | 1.35±0.1 g/cm3(Predicted) |
Boling Point | 700.8±70.0 °C(Predicted) |
Solubility | DMSO: ≥ 40.2 mg/mL |
pKa | 9.17±0.20(Predicted) |
Storage Condition | -20℃ |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.312 ml | 11.56 ml | 23.12 ml |
5 mM | 0.462 ml | 2.312 ml | 4.624 ml |
10 mM | 0.231 ml | 1.156 ml | 2.312 ml |
5 mM | 0.046 ml | 0.231 ml | 0.462 ml |
biological activity | Miransertib(ARQ-092) is an effective, selective and orally bioavailable Akt allosteric inhibitor with IC50 values of 2.7 nM, 14 nM and 8.1 nM for Akt1, Akt2 and Akt3 respectively. |
target | TargetValue Akt1 (Cell-free Assay) 2.7 nM Akt3 (Cell-free Assay) 8.1 nM Akt2 (Cell-free Assay) 14 nM |
Target | Value |
Akt1 (Cell-free assay) | 2.7 nM |
Akt3 (Cell-free assay) | 8.1 nM |
Akt2 (Cell-free assay) | 14 nM |